International Workshop on Cardiovascular Genetics and Precision Medicine
(IWCGPM-26)

12th December 2026 || Trivandrum - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Workshop on Cardiovascular Genetics and Precision Medicine (IWCGPM), scheduled to be held on 12th December 2026 in Trivandrum, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Cardiology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Cardiovascular Genetics
    This track will explore recent breakthroughs in the field of cardiovascular genetics, focusing on the identification of genetic variants associated with heart disease. Participants will discuss the implications of these findings for risk assessment and disease prevention. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Precision Medicine in Cardiology
    This session will delve into the application of precision medicine in cardiology, highlighting personalized treatment strategies based on genetic and phenotypic data. Attendees will examine case studies that demonstrate the effectiveness of tailored therapies in improving patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Genomic Medicine and Cardiovascular Disease
    Focusing on the integration of genomic medicine into cardiovascular care, this track will discuss how genomic information can inform clinical decision-making. Presentations will cover the role of genomics in understanding disease mechanisms and guiding therapeutic interventions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Translational Research in Cardiac Genetics
    This session will highlight the translation of genetic research findings into clinical practice for cardiovascular diseases. Participants will share innovative approaches to bridging the gap between laboratory discoveries and patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Emerging Biomarkers in Cardiovascular Health
    This track will focus on the discovery and validation of novel biomarkers for cardiovascular diseases, emphasizing their potential role in early diagnosis and monitoring. Discussions will include the challenges and opportunities in biomarker research. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Ethical Considerations in Cardiovascular Genomics
    This session will address the ethical implications of genetic testing and genomic research in cardiology. Experts will discuss issues related to consent, privacy, and the equitable distribution of genomic technologies. Aligned SDGs: SDG 10 – Reduced Inequalities
  • Track 07 – Innovations in Cardiovascular Imaging
    This track will showcase cutting-edge imaging technologies that enhance the understanding of cardiovascular genetics and disease. Presentations will highlight how advanced imaging techniques can aid in the diagnosis and management of heart conditions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Lifestyle and Genetic Interactions in Heart Disease
    This session will explore the interplay between genetic predispositions and lifestyle factors in the development of cardiovascular diseases. Researchers will present findings that illustrate how lifestyle modifications can mitigate genetic risks. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Pharmacogenomics in Cardiovascular Therapy
    Focusing on pharmacogenomics, this track will discuss how genetic variations influence drug responses in cardiovascular treatments. Participants will examine the potential for personalized medication regimens to enhance therapeutic efficacy and reduce adverse effects. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Population Genetics and Cardiovascular Disease
    This session will investigate the role of population genetics in understanding the epidemiology of cardiovascular diseases. Discussions will include the impact of genetic diversity on disease prevalence and treatment responses across different populations. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Future Directions in Cardiovascular Research
    This track will provide insights into the future of cardiovascular research, emphasizing emerging trends and technologies in the field. Experts will discuss the potential impact of artificial intelligence and big data on cardiovascular genetics and precision medicine. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228